AstraZeneca Shares Outstanding 1992-2025 | AZN
AstraZeneca shares outstanding history from 1992 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- AstraZeneca shares outstanding for the quarter ending June 30, 2025 were 3.118B, a 0.06% decline year-over-year.
- AstraZeneca 2024 shares outstanding were 3.126B, a 0.06% increase from 2023.
- AstraZeneca 2023 shares outstanding were 3.124B, a 0.13% increase from 2022.
- AstraZeneca 2022 shares outstanding were 3.12B, a 9.32% increase from 2021.
AstraZeneca Annual Shares Outstanding (Millions of Shares) |
|
---|---|
2024 | 3,126 |
2023 | 3,124 |
2022 | 3,120 |
2021 | 2,854 |
2020 | 2,626 |
2019 | 2,602 |
2018 | 2,534 |
2017 | 2,532 |
2016 | 2,532 |
2015 | 2,530 |
2014 | 2,528 |
2013 | 2,508 |
2012 | 2,528 |
2011 | 2,734 |
2010 | 2,892 |
2009 | 2,900 |
2008 | 2,906 |
2007 | 2,996 |
2006 | 3,140 |
2005 | 3,236 |
2004 | 3,345 |
2003 | 3,411 |
2002 | 3,463 |
2001 | 3,522 |
2000 | 3,536 |
1999 | 3,558 |
1998 | 3,558 |
1997 | 1,896 |
1996 | 1,894 |
1995 | 1,892 |
1994 | 1,892 |
1993 | 5,673 |
1992 |